Loading insider details...
Beta
Latest Form 4 (Mar 20, 2026): Grant/Award of 475,424 FBIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 20, 2026 | Fortress Biotech, Inc. (FBIO) | Grant/Award | 475,424 | n/a |
| Jan 9, 2026 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 622,000 | n/a |
| Nov 7, 2025 | TG THERAPEUTICS, INC. (TGTX) | Gift | 3,865,126 | n/a |
| Jan 30, 2025 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 750,000 | n/a |
| Jan 3, 2025 | Fortress Biotech, Inc. (FBIO) | Grant/Award | 454,153 | n/a |
| May 16, 2024 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/Award | 32,051 | n/a |
| Jan 8, 2024 | TG THERAPEUTICS, INC. (TGTX) | Grant/Award | 1,001,908 | n/a |
| Jan 3, 2024 | Fortress Biotech, Inc. (FBIO) | Grant/Award | 216,465 | n/a |
| Nov 16, 2023 | Fortress Biotech, Inc. (FBIO) | Purchase | 147,058 | $250.0K |
| Aug 14, 2023 | TG THERAPEUTICS, INC. (TGTX) | Purchase | 100,000 | $1.01M |